AYTU Earnings

Quarterly EPS
$-0.82
Q4 2024
$0.24
Q1 2025
$0.13
Q2 2025
$0.65
Q3 2025
$-2.92
Q4 2025
$0.21
Q1 2026
$-1.05
Q2 2026
$-0.53
Q3 2026
Latest Revenue12.4M
Latest Net Income-5618000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.5312.4M-5618000-32.7%-181.5%
Q2 2026-$1.0515.2M-10584000-6.5%-907.7%
Q1 2026$0.2113.9M2.0M-16.2%-12.5%
Q4 2025-$2.9215.1M-19818000+3.7%-256.1%
Q3 2025$0.6518.5M4.0M+31.6%+225.0%
Q2 2025$0.1316.2M788.0K-13.5%+425.0%
Q1 2025$0.2416.6M1.5M-7.0%+116.2%
Q4 2024-$0.8214.6M-4617000-52.5%-34.4%
Q3 2024-$0.5214.0M-2887000
Q2 2024-$0.0418.7M-220000
Q1 2024-$1.4817.8M-8120000
Q4 2023-$0.6130.7M-2457000
AYTU BioPharma (AYTU) — Earnings